UTIRA
Live / Applied — First extension granted (statement of use) (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 04 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99121663
- Mark type
- Stylized text
- Filed
- 04 Apr 2025
- Published for opposition
- 07 Oct 2025
- Attorney of record
- Pamela B. Huff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of urinary tract infections and related symptoms
Owner
- BIOCOMP PHARMA, INC., San Antonio, TX, US
- BIOCOMP PHARMA, INC., San Antonio, TX, US
Prosecution history
- 03 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2026 — SOU EXTENSION 1 GRANTED
- 02 Apr 2026 — SOU EXTENSION 1 FILED
- 02 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Sept 2025 — ASSIGNED TO EXAMINER
- 04 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 04 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Apr 2025 — NEW APPLICATION ENTERED